A New Microfluidic-nanoelectronic Platform for Alzheimer’s Disease

The main objective of this project is developing a novel technology to understand Alzheimer’s disease (AD). The main cause of AD has not been clearly discovered, and therefore the effective treatment to stop the disease has not yet been established. This technology which is an integration of microfluidic, nano-electronics, and optical imaging techniques would provide a systematic platform to study AD. Fabrication and integration of nano-structures for electrical recording and optical imaging is the main goal of this project during my Visit at Harvard University. This new technology addresses unanswered questions related to AD and sets the stage for the identification of novel pathways and therapeutic avenues in AD.

Faculty Supervisor:

Amir Sanati Nezhad

Student:

Partner:

Harvard University

Discipline:

Engineering

Sector:

Education

University:

University of Calgary

Program: